Page last updated: 2024-12-09

1-[4-[(2-amino-5-thiazolyl)methyl]phenyl]ethanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

The compound you're asking about, 1-[4-[(2-amino-5-thiazolyl)methyl]phenyl]ethanone, is more commonly known as **Thiamine** or **Vitamin B1**.

**Why is Thiamine important for research?**

Thiamine plays a vital role in many crucial metabolic processes within the body. It's a key coenzyme involved in:

* **Carbohydrate metabolism:** Thiamine is essential for the breakdown of carbohydrates, which provides the body with energy. It's a component of two important enzymes:
* **Pyruvate dehydrogenase complex (PDC):** This enzyme converts pyruvate, a product of glycolysis, into acetyl-CoA, which enters the citric acid cycle for energy production.
* **α-ketoglutarate dehydrogenase complex (KGDHC):** This enzyme is involved in the citric acid cycle.
* **Nerve function:** Thiamine is crucial for the transmission of nerve impulses. It's a component of the enzyme transketolase, involved in the synthesis of neurotransmitters like acetylcholine.
* **Muscle function:** Thiamine supports the healthy function of muscles.

**Research on Thiamine:**

Because of its vital role in various metabolic pathways, Thiamine is a subject of ongoing research in various fields, including:

* **Neuroscience:** Researchers are investigating the role of thiamine in neurodegenerative diseases like Alzheimer's disease and Parkinson's disease, as well as in conditions like Wernicke-Korsakoff syndrome, which is caused by thiamine deficiency.
* **Metabolic disorders:** Studies are looking at the relationship between thiamine deficiency and metabolic conditions like diabetes and obesity.
* **Cancer research:** Some studies suggest a potential link between thiamine and cancer prevention or treatment.
* **Nutritional studies:** Researchers are investigating the optimal intake of thiamine for different populations and its impact on overall health.

**Overall:**

Thiamine is a crucial nutrient with broad implications for human health. Research into its functions and potential therapeutic applications continues to shed light on its importance in various physiological processes.

Cross-References

ID SourceID
PubMed CID2145539
CHEMBL ID1504823
CHEBI ID120909
SCHEMBL ID3132182

Synonyms (24)

Synonym
REGID4260519
SDCCGMLS-0039299.P002
MLS000052896 ,
1-{4-[(2-amino-1,3-thiazol-5-yl)methyl]phenyl}ethanone
smr000082738
CHEBI:120909
AKOS002218934
STK864827
1-[4-[(2-amino-1,3-thiazol-5-yl)methyl]phenyl]ethanone
HMS2300G04
F1711-0028
1-(4-((2-aminothiazol-5-yl)methyl)phenyl)ethanone
838818-30-7
CHEMBL1504823
SCHEMBL3132182
1-[4-[(2-azanyl-1,3-thiazol-5-yl)methyl]phenyl]ethanone
1-[4-[(2-amino-5-thiazolyl)methyl]phenyl]ethanone
1-[4-[(2-aminothiazol-5-yl)methyl]phenyl]ethanone
bdbm68557
cid_2145539
Q27209076
SR-01000301334-1
sr-01000301334
1-(4-((2-aminothiazol-5-yl)methyl)phenyl)ethan-1-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency50.11870.044717.8581100.0000AID485294
ATAD5 protein, partialHomo sapiens (human)Potency12.99530.004110.890331.5287AID504467
thyroid stimulating hormone receptorHomo sapiens (human)Potency6.30960.001318.074339.8107AID926; AID938
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency20.59620.00419.984825.9290AID504444
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glycogen synthase kinase-3 beta isoform 1Homo sapiens (human)EC50 (µMol)300.00000.212522.156283.9400AID434954
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID652178Confirmed Agonists of Novel Allosteric Modulators of the M1 Muscarinic Receptor2013Molecules (Basel, Switzerland), Jan-08, Volume: 18, Issue:1
Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.35 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]